scispace - formally typeset
C

Cyrus Cooper

Researcher at Southampton General Hospital

Publications -  1961
Citations -  248928

Cyrus Cooper is an academic researcher from Southampton General Hospital. The author has contributed to research in topics: Population & Osteoporosis. The author has an hindex of 204, co-authored 1869 publications receiving 206782 citations. Previous affiliations of Cyrus Cooper include University of Oxford & University of York.

Papers
More filters
Journal ArticleDOI

Incidence of hip fracture in Rohtak district, North India.

Dinesh Dhanwal, +5 more
- 26 Apr 2013 - 
TL;DR: Hip fracture incidence rates in Rohtak district of India are intermediate between those in the industrialised world and Africa and similar to some of Asian countries such as China, Iran and South Korea.
Journal ArticleDOI

Public health impact of adverse bone effects of oral corticosteroids.

T P van Staa, +6 more
- 01 Jun 2001 - 
TL;DR: The targeting of high-risk patients will be important for implementing preventative strategies in a cost-effective manner and to estimate the number of fractures attributed to oral corticosteroid use.
Journal ArticleDOI

Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.

Cyrus Cooper, +6 more
- 01 Oct 2003 - 
TL;DR: It is demonstrated that oral weekly ibandronate provides the same efficacy and safety as oral daily ib andronate in women with postmenopausal osteoporosis.
Journal ArticleDOI

Current patterns of diet in community-dwelling older men and women: results from the Hertfordshire Cohort Study

Siân M Robinson, +7 more
- 01 Sep 2009 - 
TL;DR: Large variations in food consumption and nutrient intake amongst older adults that are likely to have implications for future health are described.
Journal ArticleDOI

Osteosarcopenia: where osteoporosis and sarcopenia collide.

Michael A. Clynes, +6 more
- 01 Feb 2021 - 
TL;DR: The epidemiology, pathogenesis and clinical consequences of 'osteosarcopenia' are outlined, current and potential future management strategies are explored and several biochemical pathways have been identified that are facilitating the development of several promising therapeutic agents, which target both muscle and bone.